Business · 13/07/2020Updated: 10/17/2026 · 1 min read
FDA Announces Final Guidance on Cancer Clinical Trial Eligibility Criteria for Brain Metastases
Summary
The FDA has released a final guidance for industry on cancer clinical trial eligibility criteria, specifically addressing the inclusion of patients with brain metastases, following a draft published in 2019.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →